ASSA14-10-01 Haemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) for acute decompensated heart failure: a randomised, double-blind, placebo-controlled, multicenter study

Multicenter Study ◽

Haemodynamic Effects ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

GW26-e2330 Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2015.06.796 ◽

2015 ◽

Vol 66 (16) ◽

pp. C208

Author(s):

Pengbo Wang ◽

Guo-Gan Wang ◽

Yi-Shi Li ◽

Wen-Xian Liu ◽

Shu-Gong Bai ◽

...

Keyword(s):

Heart Failure ◽

Multicenter Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

GW25-e3203 Hemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) for congestive heart failure: a randomized, double-blind, placebo-controlled study

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2014.06.844 ◽

2014 ◽

Vol 64 (16) ◽

pp. C182-C183

Author(s):

Wang Pengbo ◽

Huang Jie ◽

Tan Huiqiong ◽

Liu Wenxian ◽

Zhang Jian ◽

...

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Natriuretic Peptide ◽

Controlled Study ◽

Hemodynamic Effects ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure

Medicine ◽

10.1097/md.0000000000002947 ◽

2016 ◽

Vol 95 (9) ◽

pp. e2947 ◽

Cited By ~ 7

Author(s):

Guogan Wang ◽

Pengbo Wang ◽

Yishi Li ◽

Wenxian Liu ◽

Shugong Bai ◽

...

Keyword(s):

Heart Failure ◽

Natriuretic Peptide ◽

Efficacy And Safety ◽

Human Atrial Natriuretic Peptide ◽

Atrial Natriuretic

Randomized, double‐blind, placebo‐controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA‐RESPONSE‐AHF)

European Journal of Heart Failure ◽

10.1002/ejhf.1713 ◽

2020 ◽

Vol 22 (4) ◽

pp. 713-722 ◽

Cited By ~ 32

Author(s):

Kevin Damman ◽

Joost C. Beusekamp ◽

Eva M. Boorsma ◽

Henk P. Swart ◽

Tom D.J. Smilde ◽

...

Keyword(s):

Heart Failure ◽

Pilot Study ◽

Clinical Outcomes ◽

Double Blind ◽

Double Blind Placebo

Effect of the Adenosine A1 Receptor Antagonist, KW-3902, on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure Refractory to Maximum Doses of Conventional Diuretics: A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2006.06.281 ◽

2006 ◽

Vol 12 (6) ◽

pp. S82-S83 ◽

Cited By ~ 2

Author(s):

Michael M. Givertz ◽

Michael Tansey ◽

Leeanne L. Pearson ◽

Tara K. Fields ◽

Howard C. Dittrich

Keyword(s):

Heart Failure ◽

Renal Function ◽

Dose Escalation ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo ◽

Adenosine A1 ◽

A1 Receptor

Effect of low-dose human atrial natriuretic peptide on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer: A double-blind, placebo-controlled study

Journal of Thoracic and Cardiovascular Surgery ◽

10.1016/j.jtcvs.2011.09.003 ◽

2012 ◽

Vol 143 (2) ◽

pp. 488-494 ◽

Cited By ~ 21

Author(s):

Takashi Nojiri ◽

Kazuhiro Yamamoto ◽

Hajime Maeda ◽

Yukiyasu Takeuchi ◽

Yasunobu Funakoshi ◽

...

Keyword(s):

Lung Cancer ◽

Atrial Fibrillation ◽

Natriuretic Peptide ◽

Low Dose ◽

Pulmonary Resection ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

First Clinical Experience with ONO-4232: A Randomized, Double-blind, Placebo-controlled Healthy Volunteer Study of a Novel Lusitropic Agent for Acutely Decompensated Heart Failure

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.02.019 ◽

2016 ◽

Vol 38 (5) ◽

pp. 1109-1121 ◽

Cited By ~ 11

Author(s):

Caroline L. Ward ◽

Virginia Jamieson ◽

Toshiya Nabata ◽

John Sharpe ◽

Koji Dozono ◽

...

Keyword(s):

Heart Failure ◽

Healthy Volunteer ◽

Clinical Experience ◽

Double Blind ◽

Double Blind Placebo ◽

Acutely Decompensated Heart Failure ◽

Volunteer Study ◽

Healthy Volunteer Study

Slight Worsening of Renal Function Occurs Even by Human Atrial Natriuretic Peptide in the Treatment of Acutely Decompensated Heart Failure

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2005.08.296 ◽

2005 ◽

Vol 11 (9) ◽

pp. S312

Author(s):

Manabu Taneike ◽

Kiyoshi Kume ◽

Hideaki Kataiwa ◽

Ken-Ichi Komukai ◽

Noriko Sasaki ◽

...

Keyword(s):

Heart Failure ◽

Renal Function ◽

Natriuretic Peptide ◽

Human Atrial Natriuretic Peptide ◽

Acutely Decompensated Heart Failure ◽

Atrial Natriuretic

Effects of Hyponatremia Normalization on the Short-Term Mortality and Rehospitalizations in Patients with Recent Acute Decompensated Heart Failure: A Retrospective Study

Journal of Clinical Medicine ◽

10.3390/jcm5100092 ◽

2016 ◽

Vol 5 (10) ◽

pp. 92 ◽

Cited By ~ 4

Author(s):

Renato De Vecchis ◽

Marco Di Maio ◽

Giuseppina Di Biase ◽

Carmelina Ariano

Keyword(s):

Heart Failure ◽

Retrospective Study ◽

Short Term ◽

Short Term Mortality

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

Circulation ◽

10.1161/01.cir.79.3.491 ◽

1989 ◽

Vol 79 (3) ◽

pp. 491-502 ◽

Cited By ~ 153

Author(s):

H Drexler ◽

U Banhardt ◽

T Meinertz ◽

H Wollschläger ◽

M Lehmann ◽

...

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Controlled Trial ◽

Converting Enzyme ◽

Long Term Effects ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibition